Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram versus progressive muscle relaxation for prevention of post-ischemic stroke psychological symptoms
IRCT20251022067726N2Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of citalopram in ischemic stroke (3 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Depression score, Anxiety score and 3 more. Started Dec 2025; status: completed.
02
Drugs
citalopram
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20251022067726N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251022067726N2.